Mortality in Individuals with Childhood ADHD or Subthreshold Symptoms - a Prospective Perinatal Risk Cohort Study over 40 years

Overview

Journal BMC Psychiatry

Publisher Biomed Central

Specialty Psychiatry

Date 2022 May 9

PMID 35534804

Authors

Nella Schiavone

Maarit Virta

Sami Leppamaki

Jyrki Launes

Ritva Vanninen

Annamari Tuulio-Henriksson

Ilkka Jarvinen

Eliisa Lehto

Katarina Michelsson

Laura Hokkanen

Affiliations

Soon will be listed here.

Abstract

Background: Attention-deficit/hyperactivity disorder (ADHD) is associated with negative life outcomes and recent studies have linked it to increased mortality. These studies have examined nationwide registers or clinic-referred samples and mostly included participants up until the age of 30. No studies have investigated mortality associated with subthreshold levels of ADHD symptoms. Our aim was to analyze mortality in a perinatal risk cohort of 46-year-old adults with childhood ADHD (cADHD) and milder childhood attention problems (including hyperactivity and inattention; cAP) compared with a group with similar birth risks but no or low levels of childhood ADHD symptoms (Non-cAP). Causes of death obtained from a national register were examined.

Methods: Mortality was analyzed with Cox proportional hazard models for all-cause mortality, cause-specific mortality (natural and unnatural causes), and age-specific mortality (under and over age 30). All models were adjusted with gender. The total n in the study was 839 (cADHD n = 115; cAP n = 216; Non-cAP n = 508).

Results: By the age of 46, 11 (9.6%) deaths occurred in the cADHD group, 7 (3.2%) in the cAP group, and 20 (3.9%) in the Non-cAP group. The cADHD group had the highest mortality risk (adjusted hazard ratio = 2.15; 95% CI 1.02, 4.54). Mortality was not elevated in the cAP group (adjusted hazard ratio = 0.72; 95% CI .30, 1.72). Mortality in the cADHD group was mainly attributed to unnatural causes of death (adjusted hazard ratio = 2.82; 95% CI 1.12, 7.12). The mortality risk in the cADHD group was sixfold before age 30 (adjusted hazard ratio = 6.20; 95% CI 1.78, 21.57).

Conclusions: Childhood ADHD was associated with a twofold risk of premature death by the age of 46 in this prospective longitudinal cohort study. Our results corroborate previous findings and the morbidity of ADHD. Subthreshold levels of childhood ADHD symptoms were not linked to increased mortality. Our results suggest that mortality risk is higher in young than middle adulthood. Future studies should examine mortality associated with ADHD in different ages in adulthood to identify those in greatest risk of premature death.

Citing Articles

Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study.

ONions E, El Baou C, John A, Lewer D, Mandy W, McKechnie D Br J Psychiatry. 2025; :1-8.

PMID: 39844532 PMC: 7617439. DOI: 10.1192/bjp.2024.199.

Childhood ADHD and subthreshold symptoms are associated with cognitive functioning at age 40-a cohort study on perinatal birth risks.

Schiavone N, Virta M, Leppamaki S, Launes J, Vanninen R, Tuulio-Henriksson A Front Psychol. 2024; 15:1393642.

PMID: 39268376 PMC: 11391087. DOI: 10.3389/fpsyg.2024.1393642.

Psychosocial interventions for improving the physical health of young people and adults with attention deficit hyperactivity disorder: a scoping review.

Ward J, McBride A, Price A, Delgado T BMC Psychiatry. 2024; 24(1):569.

PMID: 39164688 PMC: 11337789. DOI: 10.1186/s12888-024-06009-2.

State of the Evidence for Use of Psychotropic Medications in School-Age Youth.

Shahidullah J, Roberts H, Parkhurst J, Ballard R, Mautone J, Carlson J Children (Basel). 2023; 10(9).

PMID: 37761415 PMC: 10528957. DOI: 10.3390/children10091454.

Adult ADHD in the Republic of Ireland: the evolving response.

Raaj S, Wrigley M, Farrelly R BJPsych Bull. 2023; 48(3):173-176.

PMID: 37718316 PMC: 11134009. DOI: 10.1192/bjb.2023.77.

References

Launes J, Hokkanen L, Laasonen M, Tuulio-Henriksson A, Virta M, Lipsanen J . Attrition in a 30-year follow-up of a perinatal birth risk cohort: factors change with age. PeerJ. 2014; 2:e480. PMC: 4103077. DOI: 10.7717/peerj.480. View

Jokela M, Ferrie J, Kivimaki M . Childhood problem behaviors and death by midlife: the British National Child Development Study. J Am Acad Child Adolesc Psychiatry. 2009; 48(1):19-24. DOI: 10.1097/CHI.0b013e31818b1c76. View

Chen V, Chan H, Wu S, Lee M, Lu M, Liang H . Attention-Deficit/Hyperactivity Disorder and Mortality Risk in Taiwan. JAMA Netw Open. 2019; 2(8):e198714. PMC: 6686778. DOI: 10.1001/jamanetworkopen.2019.8714. View

Hokkanen L, Launes J, Michelsson K . The Perinatal Adverse events and Special Trends in Cognitive Trajectory (PLASTICITY) - pre-protocol for a prospective longitudinal follow-up cohort study. F1000Res. 2013; 2:50. PMC: 3790606. DOI: 10.12688/f1000research.2-50.v1. View

Crump C . Preterm birth and mortality in adulthood: a systematic review. J Perinatol. 2019; 40(6):833-843. PMC: 7246174. DOI: 10.1038/s41372-019-0563-y. View

Chen V, Chan H, Wu S, Lu M, Dewey M, Stewart R . Methylphenidate and mortality in children with attention-deficit hyperactivity disorder: population-based cohort study. Br J Psychiatry. 2020; :1-9. DOI: 10.1192/bjp.2020.129. View

Weye N, Momen N, Christensen M, Iburg K, Dalsgaard S, Laursen T . Association of Specific Mental Disorders With Premature Mortality in the Danish Population Using Alternative Measurement Methods. JAMA Netw Open. 2020; 3(6):e206646. PMC: 7272122. DOI: 10.1001/jamanetworkopen.2020.6646. View

Shalev I, Caspi A, Ambler A, Belsky D, Chapple S, Cohen H . Perinatal complications and aging indicators by midlife. Pediatrics. 2014; 134(5):e1315-23. PMC: 4210799. DOI: 10.1542/peds.2014-1669. View

Tervo T, Michelsson K, Launes J, Hokkanen L . A Prospective 30-Year Follow-Up of ADHD Associated With Perinatal Risks. J Atten Disord. 2014; 21(10):799-810. DOI: 10.1177/1087054714548036. View

10.

MICHELSSON K, Ylinen A, Saarnivaara A, Donner M . Occurrence of risk factors in newborn infants. A study of 22359 consecutive cases. Ann Clin Res. 1978; 10(6):334-6. View

11.

Larsson H, Anckarsater H, Rastam M, Chang Z, Lichtenstein P . Childhood attention-deficit hyperactivity disorder as an extreme of a continuous trait: a quantitative genetic study of 8,500 twin pairs. J Child Psychol Psychiatry. 2011; 53(1):73-80. DOI: 10.1111/j.1469-7610.2011.02467.x. View

12.

Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods A . A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med. 2012; 10:99. PMC: 3520745. DOI: 10.1186/1741-7015-10-99. View

13.

Fitzgerald C, Dalsgaard S, Nordentoft M, Erlangsen A . Suicidal behaviour among persons with attention-deficit hyperactivity disorder. Br J Psychiatry. 2019; :1-6. DOI: 10.1192/bjp.2019.128. View

14.

Friedlander Y, Paltiel O, Deutsch L, Knaanie A, Massalha S, Tiram E . Birthweight and relationship with infant, child and adult mortality in the Jerusalem perinatal study. Paediatr Perinat Epidemiol. 2003; 17(4):398-406. DOI: 10.1046/j.1365-3016.2003.00522.x. View

15.

Barkley R, Fischer M . Hyperactive Child Syndrome and Estimated Life Expectancy at Young Adult Follow-Up: The Role of ADHD Persistence and Other Potential Predictors. J Atten Disord. 2018; 23(9):907-923. DOI: 10.1177/1087054718816164. View

16.

Schiavone N, Virta M, Leppamaki S, Launes J, Vanninen R, Tuulio-Henriksson A . ADHD and subthreshold symptoms in childhood and life outcomes at 40 years in a prospective birth-risk cohort. Psychiatry Res. 2019; 281:112574. DOI: 10.1016/j.psychres.2019.112574. View

17.

Lecendreux M, Konofal E, Cortese S, Faraone S . A 4-year follow-up of attention-deficit/hyperactivity disorder in a population sample. J Clin Psychiatry. 2015; 76(6):712-9. DOI: 10.4088/JCP.14m09555. View

18.

Sun S, Kuja-Halkola R, Faraone S, DOnofrio B, Dalsgaard S, Chang Z . Association of Psychiatric Comorbidity With the Risk of Premature Death Among Children and Adults With Attention-Deficit/Hyperactivity Disorder. JAMA Psychiatry. 2019; 76(11):1141-1149. PMC: 6686979. DOI: 10.1001/jamapsychiatry.2019.1944. View

19.

Polanczyk G, Salum G, Sugaya L, Caye A, Rohde L . Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015; 56(3):345-65. DOI: 10.1111/jcpp.12381. View

20.

Fayyad J, Sampson N, Hwang I, Adamowski T, Aguilar-Gaxiola S, Al-Hamzawi A . The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys. Atten Defic Hyperact Disord. 2016; 9(1):47-65. PMC: 5325787. DOI: 10.1007/s12402-016-0208-3. View